Alterity Therapeutics Announced New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer’s and Parkinson’s
Alterity Therapeutics (NASDAQ: ATHE) announced the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Alterity's patent application No. 17/239,375.
Alterity Therapeutics Highlights Publication Of Data; Says Data Demonstrates ATH434 Is Neuroprotective And Improves Motor Function
Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today
22 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares rose 63.2% to $8.03 in pre-market trading after jumping around 8% on Wednesday.
64 Biggest Movers From Friday
Gainers
Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share.